focus -WSS

focus

author：focus 2025-10-02 18:47:07 - browse：82

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

The blockbuster weight loss and diabetes drug sold by Eli Lilly also appears to improve fatty liver disease, according to early clinical trial data the pharmaceutical company released Tuesday.

Eli Lilly reported during its fourth-quarter earnings call that tirzepatide, which is sold commercially as Mounjaro or Zepbound, succeeded in a Phase 2 test as a treatment for the liver disease MASH. Around 74% of adults in the trial taking the drug were free of MASH after 52 weeks, compared to approximately 13% of the placebo group.

MASH, formerly known as NASH, is a liver disease characterized by excess fat and inflammation. The chronic inflammation can also lead to liver scarring, or fibrosis.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Regeneron agrees to White House price limits on anti

WSS

ALS groups 'won't be played again' by the FDA, drug sponsors

Popular nasal decongestant doesn't actually relieve congestion

White House touts steps to stem shortages of cancer treatments

Will the IRA bring competition to the biologics market?

Food makers to regulators: Ultra

Hospitals consider fixing cancer drug shortages on their own

hotspot

focus

entertainment

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

Affirmative action in medical school literally saved lives

House looks to weaken Medicare negotiation

In age of alternative facts, a scholarly course on calling out crap

A common UTI test for kids haunts adults as a traumatic 'nightmare'

Jerome Adams on the need for new antivirals for Covid

White House touts steps to stem shortages of cancer treatments

Wildfire smoke exposes gaps in outdoor worker protections

Popular nasal decongestant doesn't actually relieve congestion

entertainment

Telehealth for opioid use disorder is lifesaving

White House touts steps to stem shortages of cancer treatments

Regeneron agrees to White House price limits on anti

New Covid vaccine is recommended for everyone 6 months or older

How housing is health care on Long Island

A common UTI test for kids haunts adults as a traumatic 'nightmare'

knowledge

hotspot

explore

leisure time